Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | MIF | P14174 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7938599 | 0.89 | TSHR (0.48) | LMNACYP2A6CYP19A1MEN1KMT2A | |
| SCHEMBL9263367 | 0.87 | CA1 (0.42) | LMNACYP2A6CYP19A1MEN1KMT2A | |
| SCHEMBL28777340 | 0.81 | CYP19A1 (0.55) | LMNACYP2A6CYP19A1MEN1KMT2A | |
| SCHEMBL196588 | 0.81 | CYP19A1 (0.55) | LMNACYP2A6CYP19A1MEN1KMT2A | |
| SCHEMBL5401000 | 0.81 | LMNA (0.50) | LMNACYP2A6CYP19A1MEN1KMT2A | |
| Phosphine SCHEMBL28854143 | 0.79 | CYP19A1 (0.53) | LMNACYP2A6CYP19A1MEN1KMT2A | |
| Water SCHEMBL28855946 | 0.79 | CYP19A1 (0.53) | LMNACYP2A6CYP19A1MEN1KMT2A | |
| SCHEMBL12869567 | 0.79 | LMNA (0.47) | LMNACYP2A6CYP19A1MEN1KMT2A | |
| SCHEMBL11458379 | 0.79 | TSHR (0.52) | LMNACYP2A6CYP19A1MEN1KMT2A | |
| SCHEMBL11293097 | 0.79 | TSHR (0.52) | LMNACYP2A6CYP19A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1693405-B1 | PROTON CONDUCTING MEMBRANE AND PROCESS FOR PRODUCING THE SAME | JSR CORP (JP) | 2012-05-02 | — | — | EP | disclosed |
| EP-1845122-B1 | POLYARYLENE, PROCESS FOR PRODUCING THE SAME, SOLID POLYELECTROLYTE, AND PROTON-CONDUCTIVE FILM | JSR CORP (JP) | 2011-11-16 | — | — | EP | disclosed |
| US-8058365-B2 | Proton conducting membrane and process for producing the same | JSR CORPORATION (JP) | 2011-11-15 | — | — | US | disclosed |
| US-8039165-B2 | Proton conductive membrane comprising a copolymer | JSR CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| US-7981566-B2 | Membrane electrode assembly and polymer electrolyte fuel cell therewith | HONDA MOTOR CO., LTD. (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7893303-B2 | Polyarylene, process for producing the same, solid polyelectrolyte, and proton-conductive film | JSR CORPORATION (JP) | 2011-02-22 | — | — | US | disclosed |
| US-20100190088-A1 | MEMBRANE ELECTRODE ASSEMBLY AND POLYMER ELECTROLYTE FUEL CELL THEREWITH | HONDA MOTOR CO., LTD. (JP) | 2010-07-29 | — | — | US | disclosed |
| US-7727652-B2 | Membrane electrode assembly and polymer electrolyte fuel cell therewith | HONDA MOTOR CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| EP-1329444-B1 | Halogenated aromatic compound, (co)polymer thereof, and proton-conductive membrane comprising same | JSR CORP (JP) | 2010-05-05 | — | — | EP | disclosed |
| EP-1575115-B1 | Polymer electrolyte and proton conductive membrane | HONDA MOTOR CO LTD (JP) | 2010-02-03 | — | — | EP | disclosed |
| US-6632949-B2 | Difluoro-diamine methylene derivatives | MITSUI CHEMICALS, INC. (JP) | 2003-10-14 | — | — | US | disclosed |
| US-20030173547-A1 | Halogenated aromatic compound, (co)polymer thereof, and proton-conductive membrane comprising same | JSR CORPORATION (JP) | 2003-09-18 | — | — | US | disclosed |
| EP-1329444-A1 | Halogenated aromatic compound, (co)polymer thereof, and proton-conductive membrane comprising same | JSR Corporation (JP) | 2003-07-23 | — | — | EP | disclosed |
| US-20030004348-A1 | Halogenating agents | SONODA HIROSHI (JP) | 2003-01-02 | — | — | US | disclosed |
| US-20020172850-A1 | Polymer electrolyte membrane and solid polymer electrolyte fuel cell using same | HONDA GIKEN KOGYO KABUSHIKI KAISHA, JSR CORPORATION | 2002-11-21 | — | — | US | disclosed |
| EP-1245554-A1 | Monomer containing electron-withdrawing group and electron-donative group, and copolymer and proton-conductive membrane comprising same | JSR Corporation (JP) | 2002-10-02 | — | — | EP | disclosed |
| US-6458990-B1 | BIS(DIHYDROCARBYLAMINO)DIFLUOROMETHANE OR CYCLIC DERIVATIVES THEREOF; FORMING BY REACTING ALKALI METAL HALIDE WITH THE CORRESPONDING AMIDINIUM SALT; FLUORINATION OF ALCOHOLS, THIOPHENOLS, ALDEHYDES, AND KETONES | MITSUI CHEMICALS, INC. (JP) | 2002-10-01 | — | — | US | disclosed |
| US-20020042521-A1 | Nitrogen-based halogenating agents and process for preparing halogen-containing compounds | SONODA HIROSHI (JP) | 2002-04-11 | — | — | US | disclosed |
| US-6329529-B1 | FOR FLUORINATING OF ORGANIC COMPOUNDS, EFFICIENCY, POLLUTION CONTROL | MITSUI CHEMICALS, INC. (JP) | 2001-12-11 | — | — | US | disclosed |
| EP-0895991-A2 | Halogenating agent | Mitsui Chemicals, Inc. (JP) | 1999-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030004348-A1 | Halogenating agents | AFF1, NAF1, AFF2 | LMNA 4101/4885CYP2A6 331/4885CYP19A1 268/4885 |
| US-20020042521-A1 | Nitrogen-based halogenating agents and process for preparing halogen-containing compounds | AFF1, NAF1, CYP2F1 | LMNA 3883/4885CYP2A6 374/4885CYP19A1 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.